Abstract CT026: A phase II trial of neratinib (NER) or NER plus fulvestrant (FUL) (N+F) in HER2 mutant, non-amplified (HER2mut) metastatic breast cancer (MBC): Part II of MutHER
| Image |  |
|---|---|
| Description | scientific article published in 2021 |
| Author/s |
author: P. Kelly Marcom Frances Valdez-Albini Shana Thomas Julie Nangia Timothy Pluard Brittney Haas Alshad S. Lalani Rachel A Freedman Nancy U Lin Eric Winer |
| Publication date | July 1, 2021 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |